
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Levodopa,Carbidopa,Entacapone
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : STADA Arzneimittel
Deal Size : Undisclosed
Deal Type : Acquisition
Details : By acquiring Lobsor Pharmaceuticals, STADA gains rights to a triple fixed combination (levodopa, carbidopa, entacapone), delivered via modern pump technology, that has already been successfully launched in Nordic countries.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 02, 2020
Lead Product(s) : Levodopa,Carbidopa,Entacapone
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : STADA Arzneimittel
Deal Size : Undisclosed
Deal Type : Acquisition

Details : Levodopa is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 20, 2015
